Add to My Stocks
DAVITA INC Revenue Chart
$61.26 $0.73 (1.21%) DVA stock closing price Sep 21, 2017 (Closing)
The latest 2017-Q2 DAVITA INC revenue is 3.88B. Compare DAVITA INC revenue chart with FRESENIUS SE&CO revenue, Quest Diagnostics revenue.
DVA Revenue Chart
You can do annual as well as quarterly comparisons of DAVITA INC net sales with its competitor companies like FRESENIUS SE&CO, Quest Diagnostics. Over the 5 year period DAVITA INC revenue in 2016 was highest at 14.75B. In the latest quarter, DVA revenue 2017-Q2 has changed from 3.7B to 3.88B implying an increase of 4.87%.
DAVITA INC Quarterly Revenue
* Past 5 years Range
|Max DVA Revenue||$3.88B||Jun, 2017|
|Min DVA Revenue||$1.96B||Sep, 2012|
DAVITA INC Annual Revenue
* Past 5 years Range
|Max DVA Revenue||$14.75B||Dec, 2016|
|Min DVA Revenue||$8.19B||Dec, 2012|
DAVITA INC Annual Revenue VS Peers
|DAVITA INC Revenue||$14.75B||$13.78B||$12.8B||$11.76B||$8.19B|
|FRESENIUS SE&CO Revenue||$32.18B||$30.68B||----||----||----|
|Quest Diagnostics Revenue||$7.52B||$7.49B||$7.44B||$7.15B||$7.38B|
|American Renal Associates Holdings Revenue||$749.76M||$652.98M||$560.73M||$495.92M||----|
|Fresenius Medical Care Revenue||$17.91B||$16.74B||$15.83B||$14.61B||$13.8B|
DAVITA INC Stock Articles
DAVITA INC News
Revenue or net sales, also called topline or gross income is one of the most important financial metrics used to analyze a company. Revenue is the total amount of money that a company brings in through its various business activities, and appears as the ‘top line’ on the income statement. A company's net sales for a particular period can be found in its income statement. A healthy growth in revenue over time is generally considered good for the company, however other parameters such as profits must also be considered. We can calculate DAVITA INC profits by subtracting expenses from DAVITA INC revenue. Apart from analyzing a company's revenues over the years, it also helps to compare DAVITA INC revenue with peers FRESENIUS SE&CO topline, Quest Diagnostics topline, American Renal Associates Holdings topline; to see how the company is doing with respect to its peers.